Developing the Synergy between Biophysics and Medicinal Chemistry to Deliver Better Drugs
Strasbourg, France October 15-18, 2013
The SCT (Société de Chimie Thérapeutique, French Society of Medicinal Chemistry) and NovAliX share a major interest in early-stage drug discovery and would like to stimulate creativity in biophysics applied to drug discovery.
Because the SCT and NovAliX have developed privileged relations on the scientific level, they have decided to offer a joint prize : the SCT-NovAliX Prize (amount : 2000€), in order to distinguish an outstanding poster presentation by a young researcher involving innovative methods.
Moreover, in order to support the event, the SCT will promote the NovAliX Conference 2013 "Biophysics for Drug Discovery" through its own communication channels.
The SFB (Société Française de Biophysique, French Society of Biophysics) is supporting the NovAliX Conference 2013 "Biophysics in Drug Discovery" and will distinguish the innovative use of biophysical methods with a poster prize (amount : 500€).